01 — At a Glance
The Contract Manufacturer Nobody Knows But Defense Budgets Depend On
- 52-Week High / Low₹541 / ₹283
- Q3 FY26 Revenue₹303 Cr
- Q3 FY26 PAT₹11.2 Cr
- TTM EPS₹10.31
- Q3 EPS₹2.63
- Book Value / Share₹124
- Price to Book2.44x
- Order Book (Dec 2025)₹2,349 Cr
- Book-to-Bill Ratio1.3x
- Capacity Utilization50-60%
Flash Summary: Cyient DLM just reported Q3 revenue of ₹303 crore—down 31.7% YoY because a massive defense order completed in FY25. Sounds bad. It’s not. Q3 profit actually grew 2.18% YoY even as revenue crashed. Margins improved. Order book at ₹2,349 crore with 1.3x book-to-bill. They’re running at 50-60% capacity. P/E is 29.4x. And every major aerospace OEM on the planet has them on speed dial.
02 — Introduction
Making the Guts of Things That Fly (And Beep When You’re Sick)
Cyient DLM makes electronic components for aircraft, defense systems, medical devices, and industrial equipment. Their customer list reads like a greatest hits album of “companies you trust when your life depends on it”: Honeywell, Thales, ABB, Boeing, Bharat Electronics, Molbio Diagnostics. You’ve been flying in planes with their circuit boards for years. You’ve probably had their medical equipment scan you. You just didn’t know it.
They do circuit board assembly (70% of FY25 revenue), cable harnesses (2%), and box builds—which is a fancy way of saying “we’ll put your PCB inside a metal box and make sure it works.” Low-volume, high-mix manufacturing. Translation: customized, quality-critical, complex stuff. Every product needs validation. Every customer contract is 3–5 years long. It’s the opposite of “move fast and break things.”
Q3 FY26 looks like a disaster at first glance. Revenue crashed 31.7% YoY to ₹303 crore. But here’s the thing—it crashed because a large defense order finished executing in FY25. That order is done, delivered, certified. The company is now sitting on ₹2,349 crore of new orders waiting to ship, running at 50-60% capacity with room to double without new capex. In aerospace manufacturing logic, this is actually the setup for the next leg. Management said on the January 2026 concall: “the worst is behind us, at least from a revenue perspective.” If that’s true, and the order book ships on schedule, FY27 could be substantially better than FY26.
ICRA Rating Note (Mar 2026): ICRA AA- (Stable); cites “strong parentage with Cyient Limited holding ~52% stake,” “healthy business profile with reputed clientele,” and “order book of ~₹2,349 crore with book-to-bill ratio of ~1.5 times.” ICRA also notes “high working capital requirements” (NWC/OI at 18-38%) as a constraint. Stability outlook reflects “expected improvement in operating margins and scale over the medium term.”
03 — Business Model: Why Precision Beats Scale
Build One Thing Perfect. Then Wait 3 Years For It to Ship.
Cyient DLM’s business is textbook niche manufacturing. They don’t compete on price. They compete on quality, certification, and the ability to handle complex, low-volume product designs that require obsessive attention to detail. A Boeing 787 wing uses thousands of components from hundreds of suppliers. Cyient DLM might make one cable assembly that appears in 10 aircraft per year. But if that assembly fails in mid-flight, it’s a $250 million problem and a lawsuit that spans a decade.
Their customer concentration is high—top 5 customers = 75-80% of revenue. But that’s actually a feature, not a bug. Long-term relationships with Honeywell, Thales, ABB mean sticky revenue streams with contractual minimums. Management emphasized on the concall that they’re “participating earlier in customer design cycles,” meaning Cyient DLM is now embedded in new product development. Once you’re in the design phase of a next-gen product, switching suppliers is nearly impossible.
The IPO in July 2023 raised ₹592 crore. ~₹80 crore went to working capital (because aerospace manufacturing ties up cash in inventory), ~₹2 crore went to capex, ₹16 crore repaid borrowings. They now have capacity to double revenue without significant new capex. Manufacturing footprint: 352,461 sq ft across Mysuru, Hyderabad, and Bengaluru. They acquired Altek Electronics (US-based) in October 2024, giving them North American presence and diversified customer access. They also incorporated a US subsidiary in March 2024. Every move screams “we’re getting ready for scale.”
PCBA Revenue70%of FY25 revenue
Aerospace Exposure24%of FY25 revenue
Defense Exposure49%of FY25 revenue
Export Mix66%of FY25 revenue
Fun fact from the concall: Management stated they commenced “revenue realization from our B2S [Build-to-Spec] programs” in Q3. B2S is the holy grail—design-led, higher-margin, customer-sticky work. Currently 6-7% of FY26 revenue, expected to hit double-digit by FY27. Management flagged FY28 onwards as the period when “B2S will meaningfully contribute to both revenue and margins.” Translation: the quality of earnings is about to improve substantially.
04 — Financials Overview
Q3 FY26: The Plot Twist That Isn’t
Result type: Quarterly Results | Q3 FY26 EPS: ₹2.63 | Q3 Normalized PAT: ₹138 Mn (post one-offs) | TTM EPS: ₹10.31 | YTD book-to-bill: 1.56x
| Metric (₹ Cr) |
Q3 FY26
Dec 2025 |
Q3 FY25
Dec 2024 |
Q2 FY26
Sep 2025 |
YoY % |
QoQ % |
| Revenue | 303 | 444 | 311 | -31.71% | -2.57% |
| Operating Profit | 28 | 28 | 31 | 0.00% | -9.68% |
| OPM % | 9% | 6% | 10% | +300 bps | -100 bps |
| PAT (Reported) | 11.2 | 11 | 7 | +2.18% | +60% |
| EPS (₹) | 2.63 | 2.54 | 1.64 | +3.54% | +60.37% |
The Real Story: Revenue fell 31.7% YoY because a massive FY25 defense program finished shipping. But normalized PAT was ₹138 crore (₹103 Mn in reported, minus ₹17.75 Mn M&A evaluation cost and ₹16.3 Mn wage code impact). So operating performance? Flat to improving. Margins? Up. OPM went from 6% in Q3 FY25 to 9% in Q3 FY26. Management stated “continued strengthening of the margin profile across both revenues and on the order book,” with orders “projected to come at a much better margin than what we’ve historically delivered.” This is the opposite of a company falling apart.
💬 If revenue is down 31.7% YoY but profit is flat and margins are up, what does that tell you? Is management lowballing revenue expectations to underpromise and overdeliver? Or are they genuinely in a trough before the order book ramps?
05 — Valuation Discussion – Fair Value Range
Is 29.4x P/E for a Company Growing Into Its Order Book Insane?
